Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diederick E Grobbee

Showing results (631-640 of 795) with videos related to

Pageof 80
Sort By:
American Heart Journal|September 11, 2013
Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trialA Michael Lincoff, Jean-Claude Tardif, Bruce Neal, et al.
Journal of Clinical Medicine|December 11, 2025
Liver Fibrosis as a Predictor of Cardiovascular Risk in Patients with Severe ObesityAlina N Saidi, Willy B Theel, Vivian D de Jong, et al.
Scientific Reports|February 6, 2025
The association of HIV status and depressive symptoms in the Ndlovu Cohort studyLi Xiang Y den Boer, Karine Scheuermaier, Hugo A Tempelman, et al.
Scientific Reports|March 20, 2021
Diagnostic performance and clinical implications for enhancing a hybrid quantitative flow ratio-FFR revascularization decision-making strategyJoyce Peper, Robbert W van Hamersvelt, Benno J W M Rensing, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2006
Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic densityFränzel J B van Duijnhoven, Petra H M Peeters, Ruth M L Warren, et al.
Circulation|November 26, 2008
Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trialsMenno Vergeer, Michiel L Bots, Sander I van Leuven, et al.
The American Journal of Medicine|March 28, 2017
Post-Discharge Worsening Renal Function in Patients with Type 2 Diabetes and Recent Acute Coronary SyndromeNuccia Morici, Stefano Savonitto, Claudio Ponticelli, et al.
Hypertension (Dallas, Tex. : 1979)|August 1, 2007
Tobacco smoke exposure of pregnant mothers and blood pressure in their newborns: results from the wheezing illnesses study Leidsche Rijn birth cohortCaroline C Geerts, Diederick E Grobbee, Cornelis K van der Ent, et al.
Lancet (London, England)|July 17, 2007
Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trialMichiel L Bots, Frank L Visseren, Gregory W Evans, et al.
The Journal of Pediatrics|March 27, 2007
Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born childrenKarin J Rademaker, Cuno S P M Uiterwaal, Floris Groenendaal, et al.
Pageof 80

Showing results (631-640 of 795) with videos related to

Sort By:
Pageof 80
American Heart Journal|September 11, 2013
Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trialA Michael Lincoff, Jean-Claude Tardif, Bruce Neal, et al.
Journal of Clinical Medicine|December 11, 2025
Liver Fibrosis as a Predictor of Cardiovascular Risk in Patients with Severe ObesityAlina N Saidi, Willy B Theel, Vivian D de Jong, et al.
Scientific Reports|February 6, 2025
The association of HIV status and depressive symptoms in the Ndlovu Cohort studyLi Xiang Y den Boer, Karine Scheuermaier, Hugo A Tempelman, et al.
Scientific Reports|March 20, 2021
Diagnostic performance and clinical implications for enhancing a hybrid quantitative flow ratio-FFR revascularization decision-making strategyJoyce Peper, Robbert W van Hamersvelt, Benno J W M Rensing, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2006
Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic densityFränzel J B van Duijnhoven, Petra H M Peeters, Ruth M L Warren, et al.
Circulation|November 26, 2008
Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trialsMenno Vergeer, Michiel L Bots, Sander I van Leuven, et al.
The American Journal of Medicine|March 28, 2017
Post-Discharge Worsening Renal Function in Patients with Type 2 Diabetes and Recent Acute Coronary SyndromeNuccia Morici, Stefano Savonitto, Claudio Ponticelli, et al.
Hypertension (Dallas, Tex. : 1979)|August 1, 2007
Tobacco smoke exposure of pregnant mothers and blood pressure in their newborns: results from the wheezing illnesses study Leidsche Rijn birth cohortCaroline C Geerts, Diederick E Grobbee, Cornelis K van der Ent, et al.
Lancet (London, England)|July 17, 2007
Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trialMichiel L Bots, Frank L Visseren, Gregory W Evans, et al.
The Journal of Pediatrics|March 27, 2007
Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born childrenKarin J Rademaker, Cuno S P M Uiterwaal, Floris Groenendaal, et al.
Pageof 80